Abstract:Background: Clinical trials have generally showed a neutral effect of blood pressure (BP) reduction on clinical outcomes among acute ischemic stroke patients. We conducted a prespecified subgroup analysis to assess whether disease severity modifies the effect of early antihypertensive treatment on death and disability among patients with acute ischemic stroke. Methods: In the China Antihypertensive Trial in Acute Ischemic Stroke, 4,071 patients with acute ischemic stroke and elevated BP were randomly assigned to receive antihypertensive treatment or to discontinue all hypertension medications within 48 h of symptom onset. The primary outcome was a combination of death and major disability at 14 days or hospital discharge. In this subgroup analysis, participants were categorized into 3 groups according to their baseline NIH Stroke Scale (NIHSS) scores (0-4, 5-15, or ≥16). Results: At 24 h after randomization, mean systolic BP differences (95% CIs) were -8.5 (-10.0 to -7.1), -9.8 (-11.4 to -8.3), and -9.1 (-14.4 to -3.8) mm Hg between the treatment and control groups (all p values <0.001) for patients with a baseline NIHSS score of 0-4, 5-15, and ≥16, respectively. At day 7 after randomization, the corresponding mean systolic BP differences were -9.3 (-10.5 to -8.2), -9.1 (-10.3 to -7.8), and -10.1 (-15.1 to -5.1) mm Hg between the treatment and control groups (all p values <0.001). The primary outcome was not significantly different between the treatment and control groups at day 14 or hospital discharge among all NIHSS subgroups (p value for homogeneity = 0.66). ORs (95% CI) associated with treatment were 1.14 (0.87-1.49, p = 0.33), 1.04 (0.86-1.25, p = 0.70), and 0.67 (0.18-2.44, p = 0.54) for patients with a baseline NIHSS score of 0-4, 5-15, and ≥16, respectively. The composite outcome of death and major disability at 3-month follow-up did not differ between the 2 comparison groups for all NIHSS subgroups. In addition, vascular events and recurrent stroke were not significantly different between the 2 comparison groups at the 3-month follow-up visit among all NIHSS subgroups except that there was a suggestive risk reduction for recurrent stroke among those with an NIHSS score of 5-15 (OR 0.45, 95% CI 0.20-0.99, p = 0.05). Conclusion: Early BP reduction with antihypertensive medications did not reduce or increase the risk of death, major disabilities, recurrent instances of stroke, and vascular events in acute ischemic stroke patients with a variety of disease severities.

Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke

Systolic Blood Pressure Trajectories After Discharge And Long-Term Clinical Outcomes Of Ischemic Stroke

Blood Pressure Reduction On Two-Year Mortality And Major Disability In Acute Ischemic Stroke With Various Severities.

Abstract MP86: Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Acute Ischemic Stroke Patients by History of Hypertension and Use of Antihypertensive Medications

Twenty-four-hour Blood Pressure Trajectories and Clinical Outcomes in Patients Who Had an Acute Ischaemic Stroke

Systolic Blood Pressure Trajectories in the Acute Phase and Clinical Outcomes in 2-Year Follow-up among Patients with Ischemic Stroke

Abstract P212: Blood Pressure Lowering and Clinical Outcomes in Patients with Acute Ischemic Stroke: China Antihypertensive Trial in Acute Ischemic Stroke (CATIS)

Blood Pressure Reduction On Two-Year Mortality And Major Disability In Patients With Acute Ischemic Stroke According To Time To Treatment.

Blood Pressure Reduction in Acute Ischemic Stroke According to Time to Treatment

Blood Pressure and Early Clinical Outcome among Acute Ischemic Stroke Patients.

Magnitude of Systolic Blood Pressure Reduction and Early Achieved Blood Pressure and Clinical Outcomes After Acute Ischemic Stroke

The effect of blood pressure lowering treatment during the acute period of ischemic stroke on stroke outcome

Investigation of vascular risk factor control and secondary prevention medication compliance in acute ischemic stroke

[A Prospective Cohort Study on Blood Pressure Control and Risk of Ischemic Stroke in Patients with Hypertension].

Survey of Treatment of Hypertension among Patients with Ischemic Stroke

Abstract 137: Post-Stroke Blood Pressure Control and Follow Up Care in Real-World Setting

Early Antihypertensive Treatment And Clinical Outcomes In Acute Ischemic Stroke: Subgroup Analysis By Baseline Blood Pressure

Early Blood Pressure Reduction in Acute Ischemic Stroke with Various Severities: A Subgroup Analysis of the CATIS Trial

Intensive Versus Standard Blood Pressure Management after Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review and Meta-analysis

Abstract P174: Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Acute Ischemic Stroke Patients According to Time from Onset to Treatment

Intensive Blood Pressure Control Reduces the Risk of Progressive Hemorrhage in Patients with Acute Hypertensive Intracerebral Hemorrhage: A Retrospective Observational Study.